Company intelligence / Profile preview

Astavita

Seattle, Washington, United Stateseresources.nlb.gov.sg ↗

Ownership: Private
Development stage: Commercial

Overview

Astavita develops and markets nutraceuticals and medical foods containing natural astaxanthin. Its products are positioned for prevention or management of lifestyle-related conditions such as sarcopenia, muscle disorders, diabetes, and cognitive decline. The company’s clinical results emphasize the benefits of astaxanthin in supporting healthy aging, muscle endurance/recovery, cardiovascular health, immune support, skin condition improvement, and vision.

Therapeutic areas: Metabolic DisordersEndocrinologyNeurology
Modalities: NutraceuticalMedical foodNatural product (astaxanthin-based)
Industry: Food & Nutrition

Drug pipeline

1 asset

astaxanthin

Commercial

Indications: Physical endurance, Cardiovascular health, Eye health, Skin health

Beyond the preview

Go deeper on Astavita.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astavita.

Explore the full profile